Titlebook: endoCANNABINOIDS; Actions at Non-CB1/C Mary E. Abood,Roger G Sorensen,Nephi Stella Book 2013 Springer Science+Business Media New York 2013

forebear

Consensus

Overview of Nonclassical Cannabinoid Receptors to be present in vascular endothelium, central nervous system and, possibly, other tissues, with emphasis on GPCRs. The possible relationship with orphan GPCR is discussed in greater detail, particularly GPR18, GPR55, GPR92, GPR119, and other GPCRs, which are reportedly activated by various endogenous, plant-derived, and synthetic cannabinoids.

limber

fluffy

起皺紋

1048-6909 eir atypical cannabinoid signalling. This book provides insight into the potential medical application of cannabinoids and their therapeutic development for the treatment of human disease.978-1-4899-8846-1978-1-4614-4669-9Series ISSN 1048-6909 Series E-ISSN 2524-6488

不整齊

治愈

The Role of GPR55 in Canceression correlates with tumor malignancy. Together, these data indicate that GPR55 plays a relevant role in cancer and opens the possibility of considering this orphan receptor as a new therapeutic target and potential biomarker in oncology.

Amplify

不能逃避

https://doi.org/10.1007/978-3-0348-8946-9 complicated. Work over the last few years has found that lysophosphatidyl inositol is a major endogenous ligand for GPR55, with phytocannabinoids and endocannabinoids having a lesser role. This review briefly summarizes our current understanding of GPR55 signaling and its role in the central nervous system.

Consensus